Results of technical investigations
| CJD patients (n=25) | AD patients (n=19) | DLB patients (n=12) | |
| PSWCs in EEG | 56% (14/25) | 31% (5/16) | 8% (1/12) |
| Protein 14-3-3 in CSF | 87% (20/23) | 18% (2/11) | 0% (0/5) |
| Median NSE value in CSF (ng/ml) | 62.5 | 13 | 16 |
| (range: 15–210) | (range: 6–120) | (range: 6–22) | |
| NSE raised in CSF | 73% (16/22) | 29% (2/7) | 0% (0/5) |
PSWCs=periodic sharp wave complexes19; NSE is neuron specific enolase.